Quintan Cockerell, 43, of Palos Verdes Estates, Calif., worked with others to create and market expensive compounded medications that were intended to be tailored for individual patient needs, according to a July 12 Justice Department news release. Instead of tailoring the medications, a pharmacy designed formulations to maximize reimbursement from federal healthcare programs.
Pharmacy owners and others paid kickbacks to Mr. Cockerell and others, who recruited physicians to write prescriptions for the medications, including by creating investment opportunities so physicians who wrote prescriptions could profit from the pharmacy operations.
Mr. Cockerell was convicted in October of one count of conspiracy to defraud the U.S., one count of receiving unlawful kickbacks and one count of money laundering.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.